» Articles » PMID: 19407854

Presence of Cancer-associated Fibroblasts Inversely Correlates with Schwannian Stroma in Neuroblastoma Tumors

Overview
Journal Mod Pathol
Specialty Pathology
Date 2009 May 2
PMID 19407854
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Stromal cells have a central function in the regulation of tumor angiogenesis. Recent studies have shown that stromal myofibroblasts (cancer-associated fibroblasts) actively promote tumor growth and enhance tumor angiogenesis in many types of adult carcinomas. To evaluate the function cancer-associated fibroblasts have in neuroblastoma angiogenesis and investigate their relationship to stromal Schwann cells, we quantified cancer-associated fibroblasts in 60 primary neuroblastoma tumors and in a novel neuroblastoma xenograft model in which murine Schwann cells were induced to infiltrate into the tumor stroma. Tumor sections were examined for presence of microvascular proliferation, a hallmark of tumor angiogenesis. Cancer-associated fibroblasts were characterized by positive immunostaining for alpha-smooth muscle actin (alpha-SMA) and were distinguished from pericytes by staining negatively for high-molecular-weight caldesmon. alpha-SMA-positive cells were quantified and their number was defined as high when >1.0% of the area was positive. Associations between high cancer-associated fibroblast number, microvascular proliferation and established prognosticators were analyzed. High numbers of cancer-associated fibroblasts were associated with Schwannian stroma-poor histopathology and microvascular proliferation. Thirty-seven (80%) of the 46 Schwannian stroma-poor tumors had high numbers of cancer-associated fibroblasts in the tumor stroma compared to only 2 (14%) of the 14 Schwannian stroma-rich/dominant tumors (P<0.001). Thirty-three (89%) of 37 tumors with microvascular proliferation had high numbers of cancer-associated fibroblasts compared to 9 (40%) of 22 tumors without microvascular proliferation (P<0.001). In the xenografts with infiltrating Schwann cells (n=10), the number of cancer-associated fibroblasts per mm(2) was approximately sevenfold less than in the control xenografts without stromal Schwann cells (n=9) (mean of 51+/-30 vs 368+/-105, respectively; P<0.001). Thus, cancer-associated fibroblasts were inversely associated with presence of Schwann cells, suggesting that Schwann cells may prevent the activation of fibroblasts. A deeper understanding of the function cancer-associated fibroblasts have in neuroblastoma angiogenesis may guide future development of stroma-directed therapeutic strategies.

Citing Articles

Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma.

Mao C, Poimenidou M, Craig B Cancers (Basel). 2024; 16(16).

PMID: 39199637 PMC: 11353182. DOI: 10.3390/cancers16162865.


The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches.

Polychronopoulos P, Bedoya-Reina O, Johnsen J Cancers (Basel). 2024; 16(10).

PMID: 38791942 PMC: 11119056. DOI: 10.3390/cancers16101863.


Different Expression and Clinical Implications of Cancer-Associated Fibroblast (CAF) Markers in Brain Metastases.

Akanda M, Ahn E, Kim Y, Salam S, Noh M, Kim S J Cancer. 2023; 14(3):464-479.

PMID: 36860926 PMC: 9969586. DOI: 10.7150/jca.80115.


Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-β/IL-6 pathway in neuroblastoma.

Louault K, Porras T, Lee M, Muthugounder S, Kennedy R, Blavier L Oncoimmunology. 2022; 11(1):2146860.

PMID: 36479153 PMC: 9721439. DOI: 10.1080/2162402X.2022.2146860.


The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD Antibody Dinutuximab Beta.

Siebert N, Leopold J, Zumpe M, Troschke-Meurer S, Biskupski S, Zikoridse A Cancers (Basel). 2022; 14(19).

PMID: 36230765 PMC: 9563425. DOI: 10.3390/cancers14194842.


References
1.
Davies G, Mason M, Martin T, Parr C, Watkins G, Lane J . The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo. Int J Cancer. 2003; 106(3):348-54. DOI: 10.1002/ijc.11220. View

2.
Micke P, Ostman A . Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?. Lung Cancer. 2004; 45 Suppl 2:S163-75. DOI: 10.1016/j.lungcan.2004.07.977. View

3.
Chlenski A, Guerrero L, Yang Q, Tian Y, Peddinti R, Salwen H . SPARC enhances tumor stroma formation and prevents fibroblast activation. Oncogene. 2007; 26(31):4513-22. DOI: 10.1038/sj.onc.1210247. View

4.
Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer. 2006; 6(5):392-401. DOI: 10.1038/nrc1877. View

5.
Yang Q, Liu S, Tian Y, Salwen H, Chlenski A, Weinstein J . Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma. Cancer Res. 2003; 63(19):6299-310. View